Search

everythinglearnresearchcommunity

for

Search:↓

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Standardized tools and treatments are needed to better manage long COVID-19 in kids and teens.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Long-COVID causes more health issues after COVID-19, varying by age, sex, and infection wave.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

iPSCs are promising for studying and treating COVID-19.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Natural products might help treat COVID-19, but current drugs like hydroxychloroquine haven't worked.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

Training programs are needed to improve home COVID-19 management practices.

Training programs are needed to improve home COVID-19 management in Mangalore.

Training programs are needed to improve home COVID-19 management and educate on vital sign monitoring and danger signs.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Most people in South India lack knowledge about managing COVID-19 at home.

The pandemic worsened physical and mental challenges for women with PCOS.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Post-COVID syndrome symptoms are common and overlap with general health issues.

Women, younger age, and low BMI increase the risk of long COVID symptoms.